Mei Liu

4.2k total citations
129 papers, 3.1k citations indexed

About

Mei Liu is a scholar working on Molecular Biology, Oncology and Cancer Research. According to data from OpenAlex, Mei Liu has authored 129 papers receiving a total of 3.1k indexed citations (citations by other indexed papers that have themselves been cited), including 66 papers in Molecular Biology, 35 papers in Oncology and 21 papers in Cancer Research. Recurrent topics in Mei Liu's work include Rheumatoid Arthritis Research and Therapies (13 papers), Natural product bioactivities and synthesis (13 papers) and Bone Metabolism and Diseases (9 papers). Mei Liu is often cited by papers focused on Rheumatoid Arthritis Research and Therapies (13 papers), Natural product bioactivities and synthesis (13 papers) and Bone Metabolism and Diseases (9 papers). Mei Liu collaborates with scholars based in China, United States and Australia. Mei Liu's co-authors include Yubin Luo, Li Yu, Yufeng Xia, Jiake Xu, Zhunan Gong, Yan‐Cheng Liu, Yun‐Qiong Gu, Hong Liang, Zhen‐Feng Chen and Ke-Bin Huang and has published in prestigious journals such as ACS Nano, Gastroenterology and Nature Cell Biology.

In The Last Decade

Mei Liu

123 papers receiving 3.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Mei Liu China 34 1.2k 503 447 286 273 129 3.1k
Meei‐Ling Sheu Taiwan 36 1.1k 0.9× 335 0.7× 568 1.3× 227 0.8× 360 1.3× 101 3.2k
Ju‐Hee Lee South Korea 35 1.4k 1.1× 356 0.7× 384 0.9× 188 0.7× 213 0.8× 144 2.8k
Tao Wu China 34 1.3k 1.0× 285 0.6× 637 1.4× 239 0.8× 257 0.9× 110 3.0k
Tao Su China 35 1.7k 1.4× 418 0.8× 272 0.6× 441 1.5× 359 1.3× 125 3.6k
Jingling Jin United States 31 1.8k 1.5× 423 0.8× 322 0.7× 363 1.3× 282 1.0× 89 3.2k
Tinghong Ye China 38 1.9k 1.5× 683 1.4× 590 1.3× 445 1.6× 468 1.7× 126 4.1k
Yunfeng Zhou China 31 1.5k 1.2× 545 1.1× 396 0.9× 564 2.0× 281 1.0× 165 3.6k
Lan Luo China 31 1.7k 1.4× 300 0.6× 209 0.5× 366 1.3× 368 1.3× 114 2.9k
Satoshi Kobayashi Japan 30 1.0k 0.8× 1.1k 2.2× 326 0.7× 255 0.9× 316 1.2× 213 3.3k
Qing Huang China 32 1.6k 1.3× 679 1.3× 391 0.9× 324 1.1× 696 2.5× 107 3.7k

Countries citing papers authored by Mei Liu

Since Specialization
Citations

This map shows the geographic impact of Mei Liu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mei Liu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mei Liu more than expected).

Fields of papers citing papers by Mei Liu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mei Liu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mei Liu. The network helps show where Mei Liu may publish in the future.

Co-authorship network of co-authors of Mei Liu

This figure shows the co-authorship network connecting the top 25 collaborators of Mei Liu. A scholar is included among the top collaborators of Mei Liu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mei Liu. Mei Liu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Pan, Fei, Yun Zhang, Min Li, & Mei Liu. (2025). IL1A regulates MSU-induced apoptosis and inflammatory response through TLR4/MyD88/NF-κB signaling pathway. International Journal of Medical Sciences. 22(12). 3070–3083.
2.
Lu, Qianglan, Fei Zeng, Zhiyong Liu, et al.. (2025). Targeting Senescent Alveolar Type 2 Cells with a Gene-Editable FePt Dual-Atom Catalyst for Mitigating Idiopathic Pulmonary Fibrosis. ACS Nano. 19(25). 23162–23176.
3.
Wei, Yuling, et al.. (2025). Formononetin Alleviates MNNG-Triggered Chronic Atrophic Gastritis:Its Potential Mechanisms. Combinatorial Chemistry & High Throughput Screening. 28.
4.
Wang, Jing, et al.. (2024). Inhibitory effects of norcantharidin on titanium particle-induced osteolysis, osteoclast activation and bone resorption via MAPK pathways. International Immunopharmacology. 129. 111655–111655. 5 indexed citations
5.
Song, Dongli, Ruikang K. Wang, Mei Liu, et al.. (2024). Sodium fluoride‐induced autophagy of ameloblast‐like cells via the p‐ULk1 / ATG13 / LC3B pathway in vitro. Oral Diseases. 30(7). 4518–4527. 1 indexed citations
6.
Xue, Yang, et al.. (2024). Sophoridine exerts anti‐arthritic effects on fibroblast‐like synoviocytes and collagen‐induced arthritis in rats. Phytotherapy Research. 38(7). 3337–3351. 1 indexed citations
7.
8.
Shen, Jie, Zhu Wang, Mei Liu, et al.. (2023). LincRNA‐ROR / miR ‐145/ ZEB2 regulates liver fibrosis by modulating HERC5 ‐mediated p53 ISGylation. The FASEB Journal. 37(6). e22936–e22936. 5 indexed citations
9.
Zhang, Changdong, Mei Liu, Xueli Wang, et al.. (2023). ALP Inhibitors Inhibit Inflammatory Responses and Osteoblast Differentiation in hVIC via AKT-ERK Pathways.. PubMed. 29(1). 58–65. 2 indexed citations
10.
Rodón, Jordi, Pauline Funchain, Theodore W. Laetsch, et al.. (2022). A phase II Study of TAS-117 in Patients with Advanced Solid Tumors Harboring Germline PTEN -Inactivating Mutations. Future Oncology. 18(30). 3377–3387. 12 indexed citations
11.
Li, Meng, et al.. (2021). Function of Bile Acid Associated with Gut Microbiota. International Journal of Physical Medicine & Rehabilitation. 9(2). 1–4.
12.
Zhu, Sipin, Samuel Bennett, Yihe Li, Mei Liu, & Jiake Xu. (2021). The molecular structure and role of LECT2 or CHM‐II in arthritis, cancer, and other diseases. Journal of Cellular Physiology. 237(1). 480–488. 11 indexed citations
13.
Lü, Xiaoli, et al.. (2020). <p>Effects of miR-26a on Osteogenic Differentiation of Bone Marrow Mesenchymal Stem Cells by a Mesoporous Silica Nanoparticle - PEI - Peptide System</p>. International Journal of Nanomedicine. Volume 15. 497–511. 36 indexed citations
14.
15.
Zhou, Lin, Xuemei Ma, Shengnan Sun, et al.. (2018). Inhibitory effects of tubeimoside I on synoviocytes and collagen‐induced arthritis in rats. Journal of Cellular Physiology. 233(11). 8740–8753. 18 indexed citations
16.
Bian, Dan‐Dan, Shuang Liu, Mei Liu, et al.. (2017). Current treatment status and barriers for patients with chronic HCV infection in mainland China. Medicine. 96(34). e7885–e7885. 16 indexed citations
17.
Liu, Yan‐Cheng, Jian-Hua Wei, Zhen‐Feng Chen, et al.. (2013). The antitumor activity of zinc(II) and copper(II) complexes with 5,7-dihalo-substituted-8-quinolinoline. European Journal of Medicinal Chemistry. 69. 554–563. 97 indexed citations
18.
Zhu, Hongxia, Guo Zhang, Yan Wang, et al.. (2010). Inhibition of ErbB2 by Herceptin reduces survivin expression via the ErbB2–β‐catenin/TCF4‐survivin pathway in ErbB2‐overexpressed breast cancer cells. Cancer Science. 101(5). 1156–1162. 32 indexed citations
19.
Chen, Xiaohong, Rongbiao Pi, Yan Zou, et al.. (2009). Attenuation of experimental autoimmune encephalomyelitis in C57 BL/6 mice by osthole, a natural coumarin. European Journal of Pharmacology. 629(1-3). 40–46. 50 indexed citations
20.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Meei‐Ling Sheu Breakdown of academic impact, for papers by Ju‐Hee Lee Breakdown of academic impact, for papers by Tao Wu Breakdown of academic impact, for papers by Tao Su Breakdown of academic impact, for papers by Jingling Jin Breakdown of academic impact, for papers by Tinghong Ye Breakdown of academic impact, for papers by Yunfeng Zhou Breakdown of academic impact, for papers by Lan Luo Breakdown of academic impact, for papers by Satoshi Kobayashi Breakdown of academic impact, for papers by Qing Huang
Rankless by CCL
2026